Search Results 151-160 of 22814 for breast
placebo in combination with ado-trastuzumab emtansine (TTT-DM1) in patients with stage II-III HER2+ breast cancer with residual disease post-neoadjuvant ...
Hormone-sensitive breast cancers are fueled by the natural hormones estrogen or progesterone. A breast cancer that's sensitive to estrogen is called estrogen ...
... breast changes or problems ranging from benign breast conditions to breast cancer. The Breast Clinic helps to coordinate treatment plans and then refers ...
Breast Cancer; Breast Cancer Genetics; High Risk Breast Surveillance; Breast Cancer Survivorship; Menopause/Perimenopause; Hormone Therapy; Midlife Women's ...
Analyzing the genetic makeup of breast cancer cells to understand how DNA changes affect response to cancer treatments and personalize treatment options.
Breast cancer; Ductal carcinoma in situ; Breast conserving surgery (i.e. lumpectomy, oncoplastic breast surgery); Mastectomy (i.e. nipple-sparing, skin-sparing ...
Research. Doctors discussing imaging test results. Mayo Clinic doctors and scientists are continually working to improve breast cancer diagnosis and treatment.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.